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Abstract
Aim The Framework Programmes for Research and Tech-
nological Development (FP) are the European Union’s
funding programmes for research in Europe. The study
analyses the features of external experts involved in
evaluating the research proposals in FP6 (years 2003–
2006) in the area of Life Sciences.
Subjects and methods Experts were analysed with respect to
nationality, gender, organisational affiliation and rotation. The
correlations between the number of experts by nationality and
scientific research indicators were also explored.
Result Experts from 70 countries participated, with 70%
coming from 10 countries. The gender composition was
relatively stable, with approximately 30% of female experts.
Themajorityofexpertscamefromhighereducationestablish-
ments (51%) and 12% from industry. About 40% of experts
participated in the evaluation process two or more times. The
number of experts by nationality was linearly correlated with
gross national income (r=0.95, p<0.0001), population (r=
0.91, p<0.0001), and number of research publications in
health sciences (r=0.93, p<0.0001). However, using multi-
ple linear regression analysis, only gross national income had
partial regression coefficients significantly different from
zero (p=0.017). The observed value of experts for Italy (312)
and Belgium (155) were higher than predicted by this
regression model (231 and 71 respectively).
Conclusion The expert panels involved were balanced with
respect to nationalities, whereas the gender distribution was
lower than the target. There was a satisfactory degree of
rotation of experts between evaluation rounds. The per-
centage of experts from industry was lower than expected.
Keywords Framework programs.Evaluators.European
commission.Health research.Peer review
Introduction
The Framework Programmes for Research and Technological
Development (FP) are European Union (EU) funding pro-
grammes designed to address major basic and applied
research projects in Europe. The budgets of the FPs have
increased steadily since the first FP was introduced in 1984,
and the current seventh FP (FP7, 2007–2013) has an average
annualbudgetofmorethan7billion€(Andrè2006; European
Commission 2007).
The specific objectives and funding instruments have
changed between the consecutive FPs, but continue to keep a
strong emphasis on supporting collaborative, multidisciplinary
research between research teams in different countries. The
FPs are open to all types of research organisations, promoting
scientific collaboration between researchers in universities,
industry, small and medium enterprises (SMEs), research
centres and public authorities (European Commission 2007).
Research grants from the FPs are awarded on the basis of
applications submitted to specific calls for proposals. The
eligible applications undergo a rigorous peer review process
in order to select the best proposals for potential funding by
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sions are made using a range of criteria, including excellent
scientific quality, potential scientific and societal impact,
quality of the management team, portfolio balance, and
relevance to the overall objectives of the FP. As a
consequence, the most important factor for the funding
decision is the result of the peer review by independent
experts (European Commission 2008a). In the thematic area
of health, proposals undergo a first review in a remote step,
where a number of experts are individually evaluating and
scoring the proposals. In a second phase, the experts meet
in consensus groups to reach agreement regarding the
scoring and ranking of submitted research proposals. This
results in a prioritised ranking list of the submitted
proposals, and a recommendation to the EC for funding.
The peer review of proposals by external experts is a
crucial step in the funding decision process of the EC. It
is therefore critical that the evaluation process is carried
out according to the highest possible standards with
respect to scientific competence, fairness, and integrity.
The roles and actions of independent experts are put
forward by EU guidelines (European Commission 2008a,
2005, 2006a, 2002a). The EC maintains the database of
potential experts who can be called upon to assist with
peer reviews. The database is open to auto-registration,
with no formal assessment or validation (CORDIS 2007).
The EC encourages research institutions to submit lists of
proposed experts who could be called to assist the
Commission in the proposal evaluation process (European
Commission 2006a), and world-class experts to register as
experts. In any case, experts participate in their own personal
capacity, rather than representing the organisation with
which they are affiliated (European Commission 2006a).
The information required for registration of candidate
experts is structured in order to have an easily searchable
database, where information is selected predominantly from
pre-defined lists (“closed” questions). Every time a round of
reviews is scheduled, experts are drawn from the database
using a variety of search criteria such as keywords related to
the research area concerned. Experts are then analysed
individually, and the EC draws up a list of appropriate
independent experts, using the following selection criteria: (1)
a lack of conflict of interest; (2) an appropriate range of
competencies, expertise and experience; (3) a reasonable
balance between academic and industrial expertise; (4) a
distribution of geographical origins; and (5) a reasonable
gender balance (European Commission 2008a;E u r o p e a n
Commission 2006a; European Commission 2002a). Further-
more, a principle of “regular rotation” is applied to the
selection of experts in order to avoid that the same
individuals bring the same views, expertise and arguments
within evaluations. The whole process is monitored exter-
nally and reviewed for all calls for proposals by independent
observers (Catenhusen, Grimaud and Horvat 2007;C a h i l l
and Horvat 2008).
The aim of this paper is to review and assess the pool of
external evaluators with respect to their country of origin, type
ofaffiliation,genderandrenewal of experts calledtoparticipate
to panels (rotation). In addition, we examined as to whether the
geographical distribution of experts could be correlated with
national indicators such as national size, wealth and breadth of
scientific research. The analysis has been limited to the activity
area 1 “Life sciences, genomics and biotechnology for health”
for FP6 (European Commission 2002b).
Methods
Preparation of experts’ data
Lists of experts that participated in the evaluation of
proposals were downloaded from the CORDIS website,
where they are posted yearly (CORDIS 2006). All lists for
the activity area 1 “Life sciences, genomics and biotech-
nology for health” of FP6 (years 2003–2006) were down-
loaded and analysed. Evaluations for FP6 calls from year
2002 were held in 2003. For each expert, the following
basic information was available in the published lists:
name, gender, nationality, organisation and organisation
type. Data were reviewed to ensure consistency from one
year to the next, and for possible errors, including screening
of the names and affiliations of experts for variants of the
same name. An extensive effort was also made to review
and validate the type of organisation which the experts were
affiliated to. All organisations where the word “university”
appeared in the organisation name were, for example,
classified as “higher education establishment”.
National research indicators and statistical analyses
The possible correlation between the number of experts by
nationality, scientific research indicators or other features of
nations was explored. The indicators included: (1) population;
(2) gross national income (GNI) (World Bank 2010;K i n g
2004); and (3) numbers of published articles (years 2000–2004)
in fields pertaining to health sciences—biology, biochemistry,
clinical medicine, immunology, microbiology, molecular biol-
ogy, genetics, neurosciences and behaviour, pharmacology,
psychology and psychiatry (Thomson Reuters 2010).
Descriptive statistics were presented as medians with inter-
quartileranges(IQR).Where indicated,statisticalsignificance
wastestedwithchi-squaretestonfrequencytables(Analyse-it
for Microsoft Excel, Version 2.11, Analyse-it Software Ltd.,
2008). Pearson’s correlation coefficient r and bivariate or
multiple linear regression were computed using SPSS
Statistics 17.0 (SPSS Inc., USA).
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Nationalities and gender of experts
During the 4-year period of FP6, the EC used a total of
3,057 expert evaluations to assess research proposals
submitted for funding in the area of Life Sciences. In
2003, 799 expert evaluations were used, 983 in 2004, 672
in 2005 and 603 in 2006. Experts came from 70 different
nations but 70% of all experts came from just 10 countries,
and 22 nations contributed comprising 90% of the experts
(Table 1). During the course of FP6, 12 new countries (EU-
12 new) joined the EU. We therefore examined whether the
proportion of experts from the new Member States
increased during the period, but no clear evidence of this
was found (Fig. 1).
Nationality of Expert Male Female Total
n (%) n (%) n (% total)
Germany 275 (84) 51 (16) 326 (10.7)
Italy 208 (67) 104 (33) 312 (10.2)
United Kingdom 225 (73) 84 (27) 309 (10.1)
United States 231 (79) 62 (21) 293 (9.6)
France 182 (69) 80 (31) 262 (8.6)
Spain 116 (66) 60 (34) 176 (5.8)
Belgium 117 (75) 38 (25) 155 (5.1)
Netherlands 120 (90) 14 (10) 134 (4.4)
Sweden 74 (81) 17 (19) 91 (3.0)
Finland 47 (62) 29 (38) 76 (2.5)
Greece 48 (64) 27 (36) 75 (2.5)
Austria 48 (75) 16 (25) 64 (2.1)
Hungary 34 (59) 24 (41) 58 (1.9)
Israel 37 (67) 18 (33) 55 (1.8)
Ireland 34 (65) 18 (35) 52 (1.7)
Poland 29 (56) 23 (44) 52 (1.7)
Switzerland 39 (75) 13 (25) 52 (1.7)
Denmark 35 (69) 16 (31) 51 (1.7)
Canada 39 (89) 5 (11) 44 (1.4)
Australia 34 (81) 8 (19) 42 (1.4)
Portugal 19 (54) 16 (46) 35 (1.1)
Czech Republic 26 (76) 8 (24) 34 (1.1)
Slovenia 17 (57) 13 (43) 30 (1.0)
Japan 22 (88) 3 (12) 25 (0.8)
Norway 21 (95) 1 (5) 22 (0.7)
Estonia 16 (80) 4 (20) 20 (0.7)
Slovakia 14 (70) 6 (30) 20 (0.7)
Romania 8 (50) 8 (50) 16 (0.5)
Lithuania 6 (46) 7 (54) 13 (0.4)
Luxembourg 6 (50) 6 (50) 12 (0.4)
Malta 1 (9) 10 (91) 11 (0.4)
Argentina 6 (60) 4 (40) 10 (0.3)
Iceland 9 (90) 1 (10) 10 (0.3)
Russian Federation 5 (50) 5 (50) 10 (0.3)
Other 36 countries
a 76 (69) 34 (31) 110 (3.6)
Total 2,224 (73) 833 (27) 3,057 (100.0)
EU-15
b 1,554 (73) 576 (27) 2,130 (69.7)
EU-12 new
c 161 (61) 104 (39) 265 (8.6)
Non-EU
d 509 (77) 153 (23) 662 (21.7)
Table 1 Experts divided by
nationality and gender
aThe experts from other national-
ities were from: Latvia (8);
Croatia, India, Turkey (7); British
Indian Ocean Territory, China (6);
Cameroon, Nigeria, Serbia,
Uganda (5); Brazil, Colombia,
Cyprus, Kenya, Singapore, South
Africa, Ukraine, Venezuela (3);
Algeria, Hong Kong, Malaysia,
New Zealand, Pakistan, Sierra
Leone, Zambia (2); Afghanistan,
Chile, Costa Rica, Gabon, Leba-
non, Nepal, Rwanda, Senegal,
Thailand, Uruguay, Zimbabwe (1)
bEU-15: Austria, Belgium,
Denmark, Finland, France,
Germany, Greece, Ireland, Italy,
Luxembourg, Netherlands,
Portugal, Spain, Sweden, United
Kingdom
cEU-12 new: in 2004 Cyprus,
Czech Republic, Estonia,
Hungary, Latvia, Lithuania, Malta,
Poland, Slovakia, Slovenia; in
2007 Romania and Bulgaria
dNon-EU: all other nationalities
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27%, and the gender distribution was stable throughout
FP6. Participation of female evaluators was 24, 28, 29 and
28% respectively, for each year from 2003 to 2006. The
gender proportion was more varied when analysing data by
groups of countries. The percentage of females among
experts from the EU-12 new countries was significantly
higher than among experts from EU-15 (39% vs. 27%, p<
0.0001). For nations with at least 10 expert evaluators (the
34 nationalities listed in Table 1), the percentages of female
experts ranged between 5 and 91%, with a median value
31% (IQR=22%). Thirty-one per cent is also the value for
all 70 nationalities (IQR=40%).
Type of organisation
Table 2 summarises the affiliations of the recruited experts.
More than half of all experts (50.6%) came from higher
education establishments, while a quarter (25.5%) came
from a variety of public research institutions. Experts from
the private for-profit sector, including large companies,
SMEs, consultancy firms and service providers, represent
11.9% of all evaluators.
Table 3 shows the nationality of experts coming from
different types of organisations in the EU countries (United
Nations Statistics Division 2010). The highest percentage
of university affiliations was found among the experts from
northern EU (57%), whereas this group had the lowest
percentage of experts from other areas of the public
research sector (19%). Southern EU provided the highest
percentage of experts from public (29%) and private non-
profit organisations (12%). The highest percentages of
experts from private for-profit organisations were among
experts from northern (13%) and western EU (15%),
whereas 9% of experts from southern and eastern EU came
from this sector.
Rotation
The total number of expert evaluations used in FP6 was
3,057. However, the number of different experts was
smaller as many individuals took part in more than one
round of evaluations. When data was corrected for repeated
participation, the number of different experts involved in
FP6 for the area Life Sciences was 1,982. About 40% of
experts were involved two or more times, while a large
majority (1,192 experts, 60.1%) participating only once;
540 experts (27%) twice, 215 experts (11%) three times,
and 35 experts (2%) appeared in all 4 years.
Correlation with national indicators
We performed a bivariate correlation analysis for a set of
research and wealth indicators, and found that the number
of experts by nationality was linearly correlated with gross
national income (GNI: r=0.95, p<0.0001), population (r=
0.91, p<0.0001), and number of research publications in
health sciences (r=0.93, p<0.0001) in the EU countries.
However, using multiple linear regression to investigate
the independent effects of individual factors, only GNI had
partial regression coefficients significantly different from
zero (Table 4). Analysis of standardised residuals, applied
after multiple regression, showed that the observed value of
experts for Italy (312) and Belgium (155) were significantly
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Fig. 1 Percentages of experts from EU-15 (diamonds), EU-12 new
Member States (triangles) and non-EU countries (squares), per year
EU-15: Austria, Belgium, Denmark, Finland, France, Germany,
Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain,
Sweden, United Kingdom; EU-12 new: countries that joined EU in
2004 (Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania,
Malta, Poland, Slovakia, Slovenia) or 2007 (Romania and Bulgaria);
non-EU: all other nationalities
Table 2 Counts of evaluators by type of organization
Type of organisation n (%)
Higher education establishment 1,547 (50.6)
Public 769 (25.2)
Public research centre 638 (20.9)
Non-research public sector 75 (2.5)
International research centre 34 (1.1)
Non-research international organisation 22 (0.7)
Private non-profit 216 (7.1)
Private non-profit research centre 201 (6.6)
Non-research private non-profit 15 (0.5)
Private for-profit 365 (11.9)
Private/commercial research centre 241 (7.9)
Consultancy firms 74 (2.4)
Non-research commercial sector including SMEs 50 (1.6)
Other 160 (5.2)
Total 3,057 (100)
448 J Public Health (2011) 19:445–452higher than predicted by this regression model (231 and 71
respectively). A bivariate linear regression of the number of
experts versus GNI is depicted in Fig. 2 for illustrative
purposes.
Discussion
Peer-review evaluations are a core element of funding
decisions by most major research funding agencies. The
overall approach of the evaluation process for the FP has
been favourably reviewed by independent observers on
recurring occasions (Catenhusen, Grimaud and Horvat
2007; Cahill and Horvat 2008). However, little statistical
information about the pool of experts involved in the
evaluations has been available until now. There are very
few quantitative comparisons in the evaluation process
between different agencies, national and international. The
quantitative information that is available is generally part of
larger studies in which the evaluation process is not the
core focus. Comparison of different evaluation systems is
difficult, if not impossible, because they are established
according to varying approaches and objectives. The
present study sought to provide quantitative information
about the evaluation system and, in particular, the charac-
teristics of the evaluators involved in the EC peer-review
process.
It is a stated goal of the EC to increase the number of
women participating as experts for the FP evaluations
towards a suggested target of at least 40% (European
Commission 2008b). The hypothesis was that this would
potentially lead to an increased number of female partic-
ipants in FP7 proposals. The present analysis found that the
overall percentage of female evaluators was 27%. This
reflects an evident gender imbalance as a whole in science
and research where women are clearly under-employed
(Klinge 2008). Across the EU, 29% of researchers are
women, although the proportion of female researchers in
medical sciences in the higher education sector of the EU-25
is 40% (European Commission 2006a). In 2006, the
percentage of female evaluators of all evaluation panels of
other themes of FP6 was 34% (European Commission
2008b). The gender disproportion which was shown in the
present analysis had been repeatedly noted in other evalua-
tions of proposals (Neugebauer 2006; Wenneras and Wold
1997). As a comparison, the overall percentage of women
among the core reviewers in the US National Institute of
Health (NIH) in the years 2003–2006 (corresponding to
FP6) was 27.4% (Dumais, Lindquist and Malik 2004).
The shortage of women in the EC’s expert database
forms a major obstacle for ensuring the gender balance of
expert evaluation panels, although this situation has been
significantly improved in recent years. In 2000, women
accounted for only 16% of the experts registered in the
Table 3 Types of organisations and geographical location of EU organisations
Geographical division Higher educ. establishments Public Private non-profit Private for-profit Other Total
n (%) n (%) n (%) n (%) n (%) n (%)
North EU
a 321 (57) 110 (19) 25 (4) 72 (13) 41 (7) 569 (100)
West EU
b 465 (46) 271 (27) 64 (7) 153 (15) 51 (5) 1,004 (100)
East EU
c 111 (53) 54 (26) 8 (4) 20 (9) 17 (8) 210 (100)
South EU
d 286 (47) 177 (29) 74 (12) 55 (9) 20 (3) 612 (100)
Non EU countries 364 (55) 157 (23) 45 (7) 65 (10) 31 (5) 662 (100)
Total 1,547 (51) 769 (25) 216 (7) 365 (12) 160 (5) 3,057 (100)
aNorth EU: United Kingdom, Sweden, Finland, Ireland, Estonia, Lithuania, Latvia
bWest EU: Germany, France, Belgium, Netherlands, Austria, Denmark, Luxembourg
cEast EU: Hungary, Poland, Czech Republic, Slovenia, Slovakia, Romania, Bulgaria
dSouth EU: Italy, Spain, Greece, Portugal, Malta, Cyprus
Table 4 Multiple linear regression analysis of experts vs. national indicators
Term
a Coefficient 95% CI t statistic p
GNI (billions PPP $) 0.14 0.03 to 0.25 2.54 0.017
Population (millions) –1.03 –3.56 to 1.51 –0.83 0.413
Articles (thousands) 0.45 –0.33 to 1.22 1.18 0.248
aIntercept 20.9 (CI 7.1–34.8); CI confidence intervals; F statistic for multiple regression: 105.62 (p<0.0001)
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database were women in 2006 (Laurila and Young 2001). It
has been noted that in some cases when an expert’s
evaluation experience is necessary, a preference was given
to previously selected candidates; this may have formed a
barrier against the inclusion of women as newcomers
(Laurila and Young 2001). Furthermore, while gender
balance is one of the criteria for evaluator selection, it is
applied after the criteria of knowledge and geographical
origin (Information 2001).
An important feature of the evaluation process is the
type of organizations to which the expert evaluators are
affiliated. Experts are recruited as individuals, but their
affiliation may, nevertheless, indicate the type of experience
and background they bring into the evaluation. Experts
from higher education establishments comprised more than
half of all experts, while an additional 25% came from
various types of public research institutions. As a compar-
ison, the percentage of reviewers from universities in the
NIH panels (2003–2006, standing and non-standing
reviewers) was 81.7% (Dumais et al. 2004). The overall
percentage of experts coming from the private for-profit
sector (“industry”) was 12% in FP6, but interestingly it
increased from 10% in 2003 to 17% in 2006. This should
be seen in the light of the stated target of the EC to involve
industry, and particularly SMEs, in research activities
funded under FP6. The increased number of experts with
industry background could be a consequence of more
research proposals with industry involvement, and thus
requiring industry expertise for the evaluation. Independent
observers stated that the contribution of industrial experts to
the evaluation process was positive, increasing the diversity
and perspectives of the evaluators especially with regard to
the potential impact of the proposals (Cahill and Horvat
2008).
Use of the same experts in two or several rounds of
proposal evaluations is considered a strength as well as a
weakness. On one hand, it secures a certain degree of
stability and consistency between separate evaluations;
while on the other hand, the same scientific judgments
may prevail in several evaluations to the detriment of new
approaches. Funding agencies approach this issue differ-
ently. The NIH review system includes a core group of
reviewers (roughly 20% of the total) and non-standing
temporary reviewers who provide additional expertise
needed to enhance the review of applications received in
any given review round. There is no rotation schedule for
non-standing reviewers, who are contacted to serve on an
“as needed” basis (Dumais et al. 2004). In the EC system, a
principle of “regular rotation” is applied, and a high
turnover rate was consequently observed over the years in
FP6. However, given the wide range of topics, it may not
always be possible to find new evaluators with sufficient
and specific expertise in a niche area. Experts with specific
knowledge in a niche area, as well as broad expertise of
their field, are therefore sometimes invited several times.
However, only 2% of experts, corresponding to a total of 35
individuals, participated in evaluations in all 4 years of FP6.
A more detailed analysis revealed that these experts were
well-recognized experts in their field, having an average
publication track of more than 40 publications in peer-
reviewed journals during the last 10 years. Many of them
had a highly specialized knowledge in a niche such as
intellectual property right or vaccine manufacturing, where-
as others displayed an uncommon combination of personal
and professional background such as female scientists in
industry or senior scientists from the new EU Member
States.
The number of experts called from the different EU
nations appeared to be correlated to country size (popula-
tion), wealth (GNI) and scientific production (research
articles). Multivariate analysis showed only a statistically
significant correlation with wealth of the EU nations,
meaning that the number of experts from a given EU
country could be predicted by the GNI of the country. Only
two countries, Belgium and Italy, contributed with a
slightly larger number of experts than predicted by the
GNI, whereas all other EU countries fell within the 95%
confidence level. Geographical proximity and budget
considerations could explain the somewhat larger represen-
tation of experts from Belgium, whereas a larger share of
experts from Italy could be due to do a larger share of
Italian candidacies in the expert database.
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In conclusion, we found that over two thirds of the experts
used for the evaluation of research proposals in the thematic
area of “Life sciences, genomics and biotechnology for
health” of FP6 came from 10 countries, and the number of
experts from a given EU country seems proportional to the
GNI of the country, except for Belgium and Italy. The
majority of the experts came from higher education
establishments, whereas 12% came from industry. The
group of experts had a relatively constant and low
percentage of women (27%), with the percentage compa-
rable to other large research funders. The role and level of
expert rotation was difficult to analyse due to the limited
study period, but only a small percentage of experts were
called on multiple occasions. It should be kept in mind that
the present study was limited to a single thematic area, and
the results can, therefore, not be considered representative
for the EC research evaluation system for FP6 as a whole;
however, some indications might be of use in future
selections, especially in terms of gender proportion and
the contribution of academic versus industrial expertise.
Evaluations can and should be studied quantitatively.
This approach can be an important support tool to the
extensive qualitative assessment and external auditing of
evaluations already used by the EC, and can help highlight
merits and weaknesses. Further study on quantitative
aspects of the research evaluation process such as more
accurate comparisons between different evaluation systems
carried out by various research agencies, is necessary.
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